SCHEMBL2228826

SCHEMBL2228826

O=[C]CNC(=O)c1ccc(F)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.50
CES1 P23141 2/20 0.50
KCNQ3 O43525 4/20 0.46
KCNQ2 O43526 4/20 0.46
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
TAS1R2 Q8TE23 1/20 0.46
HDAC1 Q13547 2/20 0.45
HDAC6 Q9UBN7 1/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 1/20 0.45
KCNQ5 Q9NR82 1/20 0.44
TP53 P04637 1/20 0.44
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
HDAC3 O15379 1/20 0.43
CHRNA1 P02708 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22231515 0.85 CA12 (0.54) CES2CES1KCNQ3KCNQ2TAS1R3
SCHEMBL31366876 0.85 CA12 (0.54) CES2CES1KCNQ3KCNQ2TAS1R3
SCHEMBL532190 0.82 CES2 (0.53) CES2CES1KCNQ3KCNQ2TAS1R3
SCHEMBL8374746 0.80 NPC1 (0.51) HDAC1MEN1NPC1GAARAB9A
SCHEMBL12988882 0.79 L3MBTL1 (0.57) CES2CES1HDAC1GAAKMT2A
SCHEMBL5317183 0.79 CES2 (0.53) CES2CES1KCNQ3KCNQ2TAS1R3
SCHEMBL22824475 0.78 CHRNA1 (0.49) CES2CES1KCNQ3KCNQ2TAS1R3
SCHEMBL28310210 0.77 NR1H4 (0.58) TAS1R3TAS1R1MEN1NPC1GAA
SCHEMBL3513760 0.77 CES2 (0.52) CES2CES1KCNQ3KCNQ2HDAC1
SCHEMBL342843 0.77 KDM4E (0.56) CES2CES1KCNQ3KCNQ2KCNQ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102946879-B Protease inhibitor and application of gallium complex in preparation of medicine for treating proliferative diseases NIIKI PHARMA INC 2015-04-22 CN disclosed
WO-2011090940-A1 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY CERULEAN PHARMA INC. (US) 2011-07-28 WO disclosed